Toward an improved understanding of the precipitation behavior of weakly basic drugs from oral lipid-based formulations.

The aim of the present study was to analyze the impact of lipid-based formulation (LBF) dispersion and digestion on the precipitation behavior of weakly basic drugs. Loratadine and carvedilol were formulated in a range of LBFs and drug solubilization was analyzed under simulated dispersive and digestive conditions (fasted state). The extent of supersaturation and drug precipitation as well as the solid-state properties and redissolution behavior of precipitated drugs were assessed. X-ray powder diffraction indicated that carvedilol precipitated in a crystalline form upon dispersion, but interestingly, this drug gave an amorphous precipitate during lipolysis. In contrast, loratadine precipitated as crystalline material during both formulation dispersion and digestion. No influence of the formulation composition on the type of precipitation was observed. These results suggested that in vitro conditions (dispersive versus digestive) largely influenced the solid-state properties of precipitating weak bases. Solid-state characterization of precipitated drugs under different experimental conditions should be routinely performed in formulation screening to better understand the biopharmaceutical behavior of LBFs. Hence, these findings are of high practical importance for the pharmaceutical development and in vitro assessment of LBFs using weakly basic drugs.

[1]  M. Lucas,et al.  Direct measurement by pH-microelectrode of the pH microclimate in rat proximal jejunum , 1975, Proceedings of the Royal Society of London. Series B. Biological Sciences.

[2]  C. W. Garner.  Boronic acid inhibitors of porcine pancreatic lipase. , 1980, The Journal of biological chemistry.

[3]  Y F Shiau,et al.  Mechanisms maintaining a low-pH microclimate in the intestine. , 1985, The American journal of physiology.

[4]  M. Ikuma,et al.  Effects of aging on the microclimate pH of the rat jejunum. , 1996, Biochimica et biophysica acta.

[5]  C. Porter,et al.  Characterisation and quantification of medium chain and long chain triglycerides and their in vitro digestion products, by HPTLC coupled with in situ densitometric analysis. , 2001, Journal of pharmaceutical and biomedical analysis.

[6]  Bruno C. Hancock,et al.  What is the True Solubility Advantage for Amorphous Pharmaceuticals? , 2000, Pharmaceutical Research.

[7]  J. Dressman,et al.  Predicting the precipitation of poorly soluble weak bases upon entry in the small intestine , 2004, The Journal of pharmacy and pharmacology.

[8]  J. Dressman,et al.  Forecasting the Oral Absorption Behavior of Poorly Soluble Weak Bases Using Solubility and Dissolution Studies in Biorelevant Media , 2002, Pharmaceutical Research.

[9]  Jon Hilden,et al.  Using a novel multicompartment dissolution system to predict the effect of gastric pH on the oral absorption of weak bases with poor intrinsic solubility. , 2005, Journal of pharmaceutical sciences.

[10]  C. Porter,et al.  Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs , 2007, Nature Reviews Drug Discovery.

[11]  G. Edwards,et al.  Evaluation of the impact of surfactant digestion on the bioavailability of danazol after oral administration of lipidic self-emulsifying formulations to dogs. , 2008, Journal of pharmaceutical sciences.

[12]  Edward L. Paul,et al.  Crystallization of Organic Compounds: An Industrial Perspective , 2009 .

[13]  Patrick Augustijns,et al.  Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability? , 2009, Journal of pharmaceutical sciences.

[14]  S. Yalkowsky,et al.  Preformulation and pharmacokinetic studies on antalarmin: a novel stress inhibitor. , 2009, Journal of pharmaceutical sciences.

[15]  H. Lennernäs,et al.  Predicting Intestinal Precipitation—A Case Example for a Basic BCS Class II Drug , 2010, Pharmaceutical Research.

[16]  T. Rades,et al.  Precipitation of a poorly soluble model drug during in vitro lipolysis: characterization and dissolution of the precipitate. , 2010, Journal of pharmaceutical sciences.

[17]  Patrick Augustijns,et al.  Excipient-mediated supersaturation stabilization in human intestinal fluids. , 2011, Molecular pharmaceutics.

[18]  Georgios Imanidis,et al.  Advancing in‐vitro drug precipitation testing: new process monitoring tools and a kinetic nucleation and growth model , 2011, The Journal of pharmacy and pharmacology.

[19]  K. Goumas,et al.  Precipitation in and Supersaturation of Contents of the Upper Small Intestine After Administration of Two Weak Bases to Fasted Adults , 2011, Pharmaceutical Research.

[20]  Christel A. S. Bergström,et al.  Toward in silico prediction of glass-forming ability from molecular structure alone: a screening tool in early drug development. , 2011, Molecular pharmaceutics.

[21]  A. Müllertz,et al.  Toward the establishment of standardized in vitro tests for lipid-based formulations, part 1: method parameterization and comparison of in vitro digestion profiles across a range of representative formulations. , 2012, Journal of pharmaceutical sciences.

[22]  R Holm,et al.  Supersaturated Self-Nanoemulsifying Drug Delivery Systems (super-SNEDDS) , 2012 .

[23]  G. Edwards,et al.  Lipid digestion as a trigger for supersaturation: evaluation of the impact of supersaturation stabilization on the in vitro and in vivo performance of self-emulsifying drug delivery systems. , 2012, Molecular pharmaceutics.

[24]  H. Lennernäs,et al.  In vivo dog intestinal precipitation of mebendazole: a basic BCS class II drug. , 2012, Molecular pharmaceutics.

[25]  S. Klein,et al.  Miniaturized Transfer Models to Predict the Precipitation of Poorly Soluble Weak Bases upon Entry into the Small Intestine , 2012, AAPS PharmSciTech.

[26]  Thomas Rades,et al.  Supersaturated Self-Nanoemulsifying Drug Delivery Systems (Super-SNEDDS) Enhance the Bioavailability of the Poorly Water-Soluble Drug Simvastatin in Dogs , 2012, The AAPS Journal.

[27]  J. Dressman,et al.  An In Vitro Methodology for Forecasting Luminal Concentrations and Precipitation of Highly Permeable Lipophilic Weak Bases in the Fasted Upper Small Intestine , 2012, Pharmaceutical Research.

[28]  Bernard Van Eerdenbrugh,et al.  pH-Induced Precipitation Behavior of Weakly Basic Compounds: Determination of Extent and Duration of Supersaturation Using Potentiometric Titration and Correlation to Solid State Properties , 2012, Pharmaceutical Research.

[29]  Hywel D Williams,et al.  Strategies to Address Low Drug Solubility in Discovery and Development , 2013, Pharmacological Reviews.

[30]  P. Tso,et al.  Intestinal bile secretion promotes drug absorption from lipid colloidal phases via induction of supersaturation. , 2013, Molecular pharmaceutics.

[31]  M. Kuentz,et al.  Study of drug supersaturation for rational early formulation screening of surfactant/co‐solvent drug delivery systems , 2013, The Journal of pharmacy and pharmacology.

[32]  B. Abrahamsson,et al.  Oral bioavailability of cinnarizine in dogs: relation to SNEDDS droplet size, drug solubility and in vitro precipitation. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[33]  A. Müllertz,et al.  Toward the Establishment of Standardized In Vitro Tests for Lipid-Based Formulations, Part 3: Understanding Supersaturation Versus Precipitation Potential During the In Vitro Digestion of Type I, II, IIIA, IIIB and IV Lipid-Based Formulations , 2013, Pharmaceutical Research.

[34]  Martin Kuentz,et al.  In silico prediction of the solubility advantage for amorphous drugs - Are there property-based rules for drug discovery and early pharmaceutical development? , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[35]  Martin Kuentz,et al.  Insights into Drug Precipitation Kinetics during In Vitro Digestion of a Lipid-Based Drug Delivery System Using In-Line Raman Spectroscopy and Mathematical Modeling , 2013, Pharmaceutical Research.

[36]  D. Mcclements,et al.  New mathematical model for interpreting pH-stat digestion profiles: impact of lipid droplet characteristics on in vitro digestibility. , 2015 .